Showing results (331-340 of 2,330) with videos related to
Sort By:
Pageof 233
Clinical Drug Investigation|December 14, 2006
Renal tubular defects from antidepressant use in an older adult: An uncommon but reversible adverse drug effectGiridhar U Adiga, T S DharmarajanClinical Drug Investigation|December 14, 2006
Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitisEnzo Ierardi, Nicola Della Valle, Maurizio Cosimo Nacchiero, et al.Clinical Drug Investigation|December 21, 2006
Aripiprazole in the treatment of schizophrenia: a consensus report produced by schizophrenia experts in ItalyGiovan B Cassano, Andrea Fagiolini, Lorenzo Lattanzi, et al.Clinical Drug Investigation|June 15, 2007
A combination of lidocaine (lignocaine) and remifentanil reduces pain during propofol injectionKyunghwa Kwak, Hoyun Chung, Choonhak Lim, et al.Clinical Drug Investigation|September 1, 2009
International recommendations for the prevention and treatment of venous thromboembolism associated with cancerParham Khosravi-Shahi, Gumersindo Pérez-MangaClinical Drug Investigation|September 1, 2009
Formulation selection and pharmacokinetic comparison of fentanyl buccal soluble film with oral transmucosal fentanyl citrate: a randomized, open-label, single-dose, crossover studyNiraj Vasisht, Larry N Gever, Ignacio Tagarro, et al.Clinical Drug Investigation|September 1, 2009
Shortness of breath, a 'wearing-off' symptom in Parkinson's diseaseWaqas Khan, Sughra Naz, Abdul Qayyum RanaClinical Drug Investigation|June 2, 2011
Identifying amnestic mild cognitive impairment in primary care: a feasibility studyRachelle S Doody, Steven H Ferris, Stephen Salloway, et al.Clinical Drug Investigation|February 21, 2012
Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectableFernanda Rosa, Andreas Schreiner, Pierre Thomas, et al.Pageof 233